BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 15080482)

  • 21. Clinical outcome for MCTs of canine pinnae treated with surgical excision (2004-2008).
    Schwab TM; Popovitch C; DeBiasio J; Goldschmidt M
    J Am Anim Hosp Assoc; 2014; 50(3):187-91. PubMed ID: 24659731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intentional marginal excision of canine limb soft tissue sarcomas followed by radiotherapy.
    Demetriou JL; Brearley MJ; Constantino-Casas F; Addington C; Dobson J
    J Small Anim Pract; 2012 Mar; 53(3):174-81. PubMed ID: 22931399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second intention healing after wide local excision of soft tissue sarcomas in the distal aspects of the limbs in dogs: 31 cases (2005-2012).
    Prpich CY; Santamaria AC; Simcock JO; Wong HK; Nimmo JS; Kuntz CA
    J Am Vet Med Assoc; 2014 Jan; 244(2):187-94. PubMed ID: 24378028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes and prognostic variables associated with primary abdominal visceral soft tissue sarcomas in dogs: A Veterinary Society of Surgical Oncology retrospective study.
    Linden D; Liptak JM; Vinayak A; Grimes JA; Sandey M; Smiley W; Matz BM
    Vet Comp Oncol; 2019 Sep; 17(3):265-270. PubMed ID: 30666781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis.
    Chaffin K; Thrall DE
    Vet Radiol Ultrasound; 2002; 43(4):392-5. PubMed ID: 12175005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canine soft tissue sarcoma managed in first opinion practice: outcome in 350 cases.
    Bray JP; Polton GA; McSporran KD; Bridges J; Whitbread TM
    Vet Surg; 2014 Oct; 43(7):774-82. PubMed ID: 24724565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soft tissue sarcoma in the dog - Part 2: surgical margins, controversies and a comparative review.
    Bray JP
    J Small Anim Pract; 2017 Feb; 58(2):63-72. PubMed ID: 28160303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reductions in margin length after excision of grade II mast cell tumors and grade I and II soft tissue sarcomas in dogs.
    Milovancev M; Townsend KL; Bracha S; Gorman E; Curran K; Russell DS
    Vet Surg; 2018 Jan; 47(1):36-43. PubMed ID: 29064583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retroperitoneal sarcomas in dogs: 14 cases (1992-2002).
    Liptak JM; Dernell WS; Ehrhart EJ; Rizzo SA; Rooney MB; Withrow SJ
    J Am Vet Med Assoc; 2004 May; 224(9):1471-7. PubMed ID: 15124889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deionised water as an adjunct to surgery for the treatment of canine cutaneous mast cell tumours.
    Jaffe MH; Hosgood G; Kerwin SC; Hedlund CS; Taylor HW
    J Small Anim Pract; 2000 Jan; 41(1):7-11. PubMed ID: 10713976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of histologic tumor characteristics and size of surgical margins with clinical outcome after surgical removal of cutaneous mast cell tumors in dogs.
    Schultheiss PC; Gardiner DW; Rao S; Olea-Popelka F; Tuohy JL
    J Am Vet Med Assoc; 2011 Jun; 238(11):1464-9. PubMed ID: 21627510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intra-operative cisplatin for the treatment of canine extremity soft tissue sarcomas.
    Havlicek M; Straw RS; Langova V; Dernell WS
    Vet Comp Oncol; 2009 Jun; 7(2):122-9. PubMed ID: 19453366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histologic grade predicts recurrence for marginally excised canine subcutaneous soft tissue sarcomas.
    McSporran KD
    Vet Pathol; 2009 Sep; 46(5):928-33. PubMed ID: 19429989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incomplete surgery, local immunostimulation, and recurrence of some tumour types in dogs and cats.
    Misdorp W
    Vet Q; 1987 Jul; 9(3):279-86. PubMed ID: 3118558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome with surgical treatment of canine soft tissue sarcoma in the region of the ischiatic tuberosity: A veterinary society of surgical oncology retrospective study.
    Paulos PE; Boston S; Skinner OT; Liptak JM; Amsellem PM; Fournier Q; Wood CJ; Annoni M; Murgia D; Oblak ML; Dean BL; Baird SD; Kulendra NJ
    Vet Comp Oncol; 2022 Sep; 20(3):669-678. PubMed ID: 35420253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytological lymph node evaluation in dogs with mast cell tumours: association with grade and survival.
    Krick EL; Billings AP; Shofer FS; Watanabe S; Sorenmo KU
    Vet Comp Oncol; 2009 Jun; 7(2):130-8. PubMed ID: 19453367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative radiotherapy for canine soft tissue sarcoma.
    Forrest LJ; Chun R; Adams WM; Cooley AJ; Vail DM
    J Vet Intern Med; 2000; 14(6):578-82. PubMed ID: 11110377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Additional local therapy with primary re-excision or radiation therapy improves survival and local control after incomplete or close surgical excision of mast cell tumors in dogs.
    Kry KL; Boston SE
    Vet Surg; 2014 Feb; 43(2):182-9. PubMed ID: 24392683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
    Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
    J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994-2002).
    Cahalane AK; Payne S; Barber LG; Duda LE; Henry CJ; Mauldin GE; Frimberger AE; Cotter SM; Moore AS
    J Am Vet Med Assoc; 2004 Aug; 225(3):401-8. PubMed ID: 15328716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.